Siemens aims for 100 percent independently verified environmental product declarations by 2030

Anthony Casciano
Anthony Casciano
0Comments

Siemens has announced a new partnership aimed at improving the generation of environmental product declarations (EPDs) across its product portfolio. EPDs provide detailed information about a product’s environmental impact, including data on CO₂ emissions, energy use, resource consumption, and waste generation. These declarations help customers make more informed decisions by offering transparency and comparability between products.

“This partnership allows Siemens to expand the consistent, reproducible and high-quality generation of verified EPDs”, said Eva Riesenhuber, Global Head of Sustainability at Siemens. “It is a proof-point how large-scale integration of industrial digitalization supports environmental compliance and shows our leadership position in scaling sustainability impact.”

Håkon Hauan, Managing Director at EPD-Global, added: “By making environmental transparency scalable and efficient, Siemens is helping shape a more sustainable industrial future. We’re proud to support Siemens in setting a new benchmark for digitalized, high-quality EPD generation. This ensures that Siemens’ EPDs meet the highest standards of transparency and credibility.”

Currently, EPDs are required in certain sectors such as construction. However, with tightening global regulations around sustainability reporting and compliance, they are becoming increasingly important in other markets as well.

Siemens already provides ISO-compliant self-declared EPDs for over half its products. The company now plans to significantly increase the number of independently verified EPDs following certification of its internal creation process. This move will enable Siemens to efficiently scale up third-party verified declarations with an aim for full coverage by 2030.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.